###### Strengths and limitations of this study

-   Large contemporary cohort from a tertiary centre.

-   Clearly defined neonatal outcomes following a category 1 caesarean section at term.

-   Results may help in identifying maternal/fetal risk factors that predispose to intrapartum compromise.

-   Retrospective study.

-   Not all neonatal outcomes were captured.

-   Only relevant to term appropriately grown babies.

Introduction {#s1}
============

Perinatal outcomes following emergency caesarean section (CS) depend on the gestation that the CS is performed as well as the indication for the emergent delivery. What is clear is that women who undergo CS not surprisingly have higher rates of complications including infection and pain, repeat admission, delayed mother--child bonding, difficulty in breast feeding as well as complications in future pregnancies.[@R1] In addition to maternal complications, there are significant neonatal consequences as well, including increased rates of admission to hospital, respiratory and neurological morbidity and mortality.[@R7] In the UK, almost two-thirds of CS performed were emergency cases.[@R11] In high-income settings, electronic fetal monitoring, prenatal and intrapartum ultrasound, obstetric facilities with availability for immediate operative delivery and advanced neonatal care all help reduce the risk of an intrapartum event resulting in adverse neonatal outcomes. These resources are largely unavailable in low-income countries.

Classification of the degree of urgency of CS is generally based on one of four categories:[@R12] category 1---immediate threat to life (maternal or fetal); category 2---maternal or fetal compromise that is not immediately life-threatening; category 3---needing early delivery but no maternal or fetal compromise or category 4---delivery at the convenience of the patient or obstetric team. Professional bodies such as the American College of Obstetrics and Gynaecology, National Institute of Clinical Excellence in the UK and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists all have broadly similar recommendations in that the decision-to-delivery interval for category 1 CS should be no longer than 30 min.

Category 1 CS, particularly in the setting of fetal compromise, carry significant risks with higher rates of complications.[@R13] [@R14] While the mode of delivery may not influence outcomes at very preterm gestations because of the confounding influence of gestation, this is not the case for term deliveries. The aim of this study therefore was to investigate neonatal outcomes following a category 1 CS at term and to ascertain obstetric factors that might influence these outcomes.

Methods {#s2}
=======

This was a retrospective observational study of category 1 CS for term (37--42 weeks) singleton deliveries at the Mater Mothers\' Hospital in Brisbane, Australia between May 2007 and June 2014. The Mater Mothers' Hospital is the largest maternity hospital in Australia and delivers approximately one in six of all babies born in Queensland (approximately 60 000 births annually). A category 1 CS was defined as a CS that required a decision-to-delivery time interval of not more than 30 min for any indication that posed an immediate threat to the life of the woman or her fetus.

Maternal demographic data and perinatal outcome data were collected from the hospital\'s maternity database and cross-referenced with the maternal and fetal medicine and neonatal databases to ensure robust data ascertainment for maternal demographics, gestation and mode of delivery and neonatal outcomes. Exclusion criteria included privately insured patients, multiple pregnancy, known fetal demise at any gestation but prior to labour, known lethal abnormality or confirmed aneuploidy. Gestational age was calculated from either the last menstrual period or by the earliest ultrasound examination.

Demographic information collected included body mass index (BMI), maternal age, mode of conception (spontaneous vs assisted), maternal medical conditions (hypertension/preeclampsia, thyroid disease and diabetes mellitus) and smoking history. Perinatal outcome data included low Apgar scores defined as \<7 at 5 min, need for neonatal resuscitation or neonatal complications as defined by the attending neonatologist (eg, respiratory distress), neonatal intensive care unit (NICU) admission, neonatal seizures and death prior to discharge. Neonatal death was defined as death in the first 28 days following birth. This study did not investigate maternal outcomes or complications relevant to the mode of delivery. Data on the indication for CS (non-reassuring fetal status, failure to progress in labour, malpresentation, failed instrumental delivery, antepartum haemorrhage (APH)/placenta praevia, maternal disease, and cord prolapse, repeat CS in labour and other) and incidence of postpartum haemorrhage were also collected. The fetal heart rate patterns, defined as non-reassuring fetal status, were classified as either suspicious or pathological heart rate patterns as defined by the National Institute of Clinical Excellence.[@R15] It was not possible to discriminate between women admitted in spontaneous labour and those being induced.

Normally distributed variables were compared using a two sample t test or analysis of variance if there were three or more groups. Non-normally distributed variables were compared using a Wilcoxon rank-sum test for two groups or the Kruskal-Wallis test if there were three or more groups. Frequencies were compared using a χ^2^ test. The proportion of infants in each category of indication for CS was compared using a z test for two proportions. The level of significance was 0.05. Summary statistics are reported as mean (SD) or median (IQR) as appropriate. Statistical analysis for this study was performed using the Stata statistics program (<http://www.stata.org>).

Results {#s3}
=======

Over the study period, a total of 30 719 women fulfilling the inclusion criteria were included in the study. The overall emergency CS rate for term singleton pregnancies was 15.3% (4706/30 719). Of these, 1179 women (3.8%) required a category 1 CS for delivery and 3527 women (11.5%) had emergency CS for other indications. Maternal demographics and indications for the CS are presented in [table 1](#BMJOPEN2014007248TB1){ref-type="table"}. Neonatal outcomes are shown in [table 2](#BMJOPEN2014007248TB2){ref-type="table"}. The median age for both cohorts was 30 years (IQR 26--34). Caucasian ethnicity was most common for both cohorts, accounting for 52.7% (621/1158) of the category 1 cohort and 52.4% (1847/3527) of the non-category 1 cohort,respectively. Country of birth, defined as either born in Australia, or born outside of Australia, was not significantly different between the two cohorts, with 49.4% of women (582/1158) born in Australia and 50.6% (597/1158) born outside of Australia for the category 1 cohort; and 50.8% (1792/3527) born in Australia and 49.2% (1735/3527) born outside of Australia for the non-category 1 cohort.

###### 

Maternal demographics---term category 1 CS, and term non-category 1 CS

                                            Term category 1 CS (n=1179)   Other term emergency CS (exclusion category 1 CS) (n=3527)   p Value
  ----------------------------------------- ----------------------------- ------------------------------------------------------------ ----------
  Age\*                                     30 (26--34)                   30 (26--34)                                                  0.33
  BMI\*                                     23.4 (20.6--27.2)             23.7 (20.9--28)                                              0.007
  Ethnicity                                                                                                                            
   Caucasian                                621 (52.7)                    1847 (52.4)                                                  
   ATSI                                     38 (3.2)                      92 (2.6)                                                     0.30
   Asian                                    287 (24.3)                    842 (23.9)                                                   0.80
   Other/not listed                         233 (19.8)                    746 (21.2)                                                   0.27
  Born in Australia                         582 (49.4)                    1792 (50.8)                                                  
  Born outside of Australia                 597 (50.6)                    1735 (49.2)                                                  0.4
  *Medical history*                                                                                                                    
  Hypertension                                                                                                                         
   Chronic hypertension                     11 (0.9)                      45 (1.3)                                                     0.44
   Gestational hypertension                 14 (1.2)                      80 (2.3)                                                     0.02
   Preeclampsia                             14 (1.2)                      46 (1.3)                                                     0.65
   No hypertension                          1140 (96.7)                   3356 (95.2)                                                  
  Diabetes mellitus                                                                                                                    
   No known diabetes                        1145 (97.1)                   3411 (96.7)                                                  
   Gestational diabetes                     6 (0.5)                       13 (0.4)                                                     0.59
   Type 1 diabetes mellitus                 4 (0.3)                       10 (0.3)                                                     0.76
   Type 2 diabetes mellitus                 2 (0.2)                       10 (0.3)                                                     0.75
   Diabetes mellitus---indeterminate type   22 (1.9)                      82 (2.3)                                                     0.36
  Thyroid disease                           5 (0.4)                       20 (0.6)                                                     0.82
  CS indication                                                                                                                        
   Non-reassuring fetal status              777 (65.9)                    671 (19)                                                     \<0.0001
   Failure to progress                      119 (10.1)                    1641 (46.5)                                                  \<0.0001
   Malpresentation                          68 (5.8)                      437 (12.4)                                                   0.11
   Failed instrumental                      97 (8.2)                      56 (1.6)                                                     0.09
   APH/placenta praevia                     40 (3.4)                      31 (0.9)                                                     0.49
   Maternal disease                         16 (1.4)                      70 (2)                                                       0.87
   Cord prolapse/presentation               25 (2.1)                      7 (0.2)                                                      0.73
   Repeat CS                                14 (1.2)                      424 (12)                                                     0.21
   Other                                    23 (2)                        190 (5.4)                                                    0.48
  PPH (Number (%))                          22 (1.9)                      48 (1.4)                                                     0.213

Data presented as N (percentage) unless otherwise specified.

\*Data presented as median (IQR).

ATSI, Aborigional and Torres Strait Islanders; APH, antepartum haemorrhage; BMI, body mass index; CS, caesarean section; PPH, postpartum haemorrhage.

###### 

Perinatal outcomes---term category 1 CS, and term non-category 1 CS

                                Term category 1 CS (n=1179)   Other term emergency CS (exclusion category 1 CS) (n=3527)   p Value
  ----------------------------- ----------------------------- ------------------------------------------------------------ ----------
  Gestation at delivery\*       40 (40--41)                   40 (38--41)                                                  \<0.0001
  Birth weight (g)\*            3420 (3095--3770)             3550 (3190--3920)                                            \<0.0001
  Apgar \<7 at 1 min            241 (20.4)                    377 (10.7)                                                   \<0.0001
  Apgar \<7 at 5 min            68 (5.8)                      67 (1.9)                                                     \<0.0001
  Umbilical arterial pH \<7.2   279 (23.7)                    321 (9.1)                                                    \<0.0001
  Respiratory distress          193 (16.4)                    266 (7.5)                                                    \<0.0001
  Neonatal resuscitation        706 (59.9)                    1828 (51.8)                                                  \<0.0001
  NICU admission                116 (9.8)                     87 (2.5)                                                     \<0.0001
  Seizure                       10 (0.8)                      9 (0.3)                                                      0.013

Data presented as N (percentage) unless otherwise specified.

\*Data presented as median (IQR).

CS, caesarean section; NICU, neonatal intensive care unit.

Women in the category 1 CS cohort had lower BMIs (23.4, IQR 20.6--27.2) compared with the non-category 1 cohort (23.7, IQR 20.9--28; p=0.007). There was no difference in the rates of maternal medical conditions between the two groups. Within the category 1 cohort, the most common indication for delivery was non-reassuring fetal status (65.9%, 777/1179), followed by malpresentation (10.1%, 119/1158), and failed instrumental (8.2%, 97/1158). Within the non-category 1 cohort, the most common indication for emergency CS was failure to progress (46.5%, 1641/3527), followed by non-reassuring fetal status (19%, 671/3527) and malpresentation (12.4%, 437/3527; [table 1](#BMJOPEN2014007248TB1){ref-type="table"}).

Median gestational age at birth was similar for both cohorts (40 weeks); however, the slight difference in distribution (IQR 39--41 for category 1 CS compared with IQR 38--41 for non-category 1 CS) resulted in a statistically significant difference, most likely due to the large numbers in each group. The median birth weight for babies delivered by a category 1 CS was 3420 g (IQR 3095--3770) compared with 3550 g (IQR 3190--3920) for the non-category 1 group. Perinatal outcomes, including Apgar scores at 1 and 5 min, umbilical arterial pH, respiratory distress, need for resuscitation and NICU admission, were significantly worse in the category 1 cohort ([table 2](#BMJOPEN2014007248TB2){ref-type="table"}). There were no intrapartum or neonatal deaths in either the category 1 or non-category 1 cohorts.

Discussion {#s4}
==========

The results from this study demonstrate the significantly worse perinatal outcomes for women who undergo a category 1 CS at term. Although the overall rates of emergency CS for non-reassuring fetal status in the entire cohort was relatively low (4.7%, 1448/30 719), it is in this category of cases that the most adverse neonatal outcomes occurred.

The predominant indication for delivery in this cohort was non-reassuring fetal status which occurred in almost two-thirds of all cases compared to 19% for non-category 1 cases. Not surprisingly, failed instrumental delivery, cord presentation/prolapse and APH/placenta praevia also featured more commonly in the category 1 group as all these indications have potentially significant fetal or maternal consequences if delivery is not achieved rapidly. Our study did not have any cases of intrapartum demise or neonatal death in either CS cohort. This may reflect the standard of obstetric, anaesthetic and neonatal care in a major metropolitan teaching hospital with all the relevant facilities and expertise readily available. Although babies that are growth restricted are at increased risk of intrapartum complications,[@R16] we did not find such an association in our study. Despite being statistically significant, the median birth weight discordance between category 1 and non-category 1 emergency CS (3420 g vs 3550 g) was small. This is unlikely to be of any clinical significance and does not suggest obvious significant suboptimal growth in either cohort. Although our study specifically looked at term fetuses and demonstrated a difference in neonatal outcomes, older studies did not show a similar difference in a term cohort when preterm newborns were excluded from analysis.

To improve care in labour, the American College of Obstetrics and Gynaecology,[@R17] the Royal Australian and New Zealand College of Obstetricians and Gynaecologists[@R18] and the National Institute of Clinical Excellence[@R15] in the UK as well as professional bodies in other countries have all published guidelines for intrapartum fetal monitoring as well as recommendations for regular training for obstetric healthcare providers. There is some evidence that such guidelines and training programmes have resulted in a reduction in the incidence of serious complications such as hypoxic ischaemic encephalopathy.[@R19] Nevertheless, the ideal decision-to-incision interval remains controversial, particularly because of the lack of good evidence of adverse neonatal outcomes, despite many institutions failing to achieve the universal 30 min standard.[@R20]

Although acute intrapartum events severe enough to cause profound hypoxia or death in the fetus are fortunately relatively rare, suboptimal intrapartum care or failure to recognise signs of developing fetal compromise is not. In the USA, it is estimated that the complication rate during labour and delivery is 2.8%, with 27.7% of those attributed to negligence and nearly 10% of adverse events being associated with serious disability.[@R21] Furthermore, current available evidence from both clinical and neuroradiological studies suggests that most cases of neonatal encephalopathy are of peripartum origin.[@R22]

Although it is likely that better training and adherence to intrapartum monitoring guidelines will improve outcomes, it is clearly preferable to identify fetuses at risk of intrapartum compromise before labour. There is emerging evidence that in term, appropriately grown babies, the cerebroumbilical ratio and umbilical venous flow rate[@R27] [@R28] may be helpful in stratifying pregnancies at risk of intrapartum compromise and of requiring emergency CS for delivery. The risks of birth are considerable and it has recently been demonstrated that the likelihood of death on the day of birth exceeds that of any other day until early in the tenth decade of life.[@R29]

The ability to identify women with pregnancies that are apparently low risk at first glance but who are actually at high risk of intrapartum fetal compromise, may allow for these women to be offered alternative delivery options or enhanced monitoring in labour with recourse to early CS if any concerns developed intrapartum. This approach would have the benefit of obviating the risks associated with labour and reduce neonatal complications associated with intrapartum hypoxia. Clearly, there would be a trade-off in terms of maternal operative risks; however, it is likely that the judicious use of appropriate obstetric intervention will result in an immediate decrease in intrapartum and neonatal mortality rates which are currently disproportionately over-represented in low-income and middle-income countries.[@R30]

In a thought-provoking hypothetical scenario, Hankins *et al*[@R31] demonstrated that if a near universal CS for all women at 39 weeks was performed in the USA, this would theoretically prevent 6000 fetal deaths annually and would reduce by 83% the number of newborns with moderate or severe neonatal hypoxic encephalopathy. While this is clearly not a practical solution, it is not unreasonable to suppose that such an approach for a small segment of women who are at high risk of intrapartum fetal compromise may be one option to reduce neonatal morbidity and mortality. Conversely, in healthcare settings with only limited resources for intrapartum monitoring, a more liberal use of CS to deliver babies that are at high risk of intrapartum compromise will certainly increase the overall rates of operative delivery. This may not be such a bad thing, as in these countries operative delivery rates are probably too low and a slight increase in these rates could translate into tangible improvements in perinatal outcomes.

There has been much debate regarding the optimum CS rate that an institution or nation should aspire to with the WHO recommending that CS rates should not exceed 15%. Nevertheless, CS rates worldwide are steadily increasing with rates in the USA now \>30%[@R8] [@R32] [@R33] with similar rises in Australia.[@R34] Regardless of the debate of the optimal CS rate, as category 1 CS in high-income countries account for only \<7% of all CS performed, in our view if reduction of the CS rate is the desired aim, then this is more likely to be achieved by improved management of labour and a reduction in the rates of elective CS for 'soft' indications.

Although a recent study[@R35] suggested that NICU admission was a poor outcome measure for neonatal morbidity when comparing different birth settings, this is not particularly relevant to our study as our study was conducted in a single tertiary centre. Furthermore, we used a composite of various other measures of neonatal well-being at birth to enhance the rigour of outcome measure.

The results of this study demonstrate the need for careful consideration of antenatal and intrapartum risk factors that may lead to a category 1 CS. It may be possible in the future to reduce the rates of emergency intrapartum CS for non-reassuring fetal status by prenatally identifying babies at risk of intrapartum compromise. Refinements of such techniques as well as early recognition of antenatal and intrapartum risk factors are important in order to optimise maternal and neonatal outcomes.
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